Understanding illicit drug markets, supply-reduction efforts, and drug-related crime in the European Union
ResearchPublished Feb 16, 2010
ResearchPublished Feb 16, 2010
The European Drugs Strategy concentrates on demand reduction and supply reduction through international cooperation and research, information and evaluation. However, efforts to provide insight in the different aspects of Europe’s illicit drug problems have largely focused on indicators developed to assess demand-side strategies. The development of measures capturing dimensions of the supply of different illicit substances is an emerging field in the EU. To advance these efforts, the European Commission DG Justice, Freedom and Security commissioned a study to recommend indicators for improving the understanding of illicit drug markets, supply reduction efforts, and drug-related crime in the EU. In this study we reviewed literature and RAND’s previous work in this area, and we gathered insights from European experts and policymakers.
Based on these insights and a conceptual framework for thinking about drug markets, we develop a number of immediate-term, near-term, and long-term recommendations. These recommendations will improve both Member States’ and the European Commission’s ability to monitor drug markets and drug-related crime as well as initiate analyses regarding the effectiveness of supply reduction strategies.
The research in this report was prepared for the European Commission, DG Justice, Freedom and Security and conducted by RAND Europe.
This publication is part of the RAND technical report series. RAND technical reports, products of RAND from 2003 to 2011, presented research findings on a topic limited in scope or intended for a narrow audience; discussions of the methodology employed in research; literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; and preliminary findings. All RAND technical reports were subject to rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.